Review





Similar Products

93
MedChemExpress qs 21
Qs 21, supplied by MedChemExpress, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/qs+21/pmc12752581-236-25-30?v=MedChemExpress
Average 93 stars, based on 1 article reviews
qs 21 - by Bioz Stars, 2026-07
93/100 stars
  Buy from Supplier

86
Agenus Inc stimulontm qs 21
Stimulontm Qs 21, supplied by Agenus Inc, used in various techniques. Bioz Stars score: 86/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/qs+21/us12558417-189-72-74?v=Agenus+Inc
Average 86 stars, based on 1 article reviews
stimulontm qs 21 - by Bioz Stars, 2026-07
86/100 stars
  Buy from Supplier

86
Agenus Inc qs 21
Qs 21, supplied by Agenus Inc, used in various techniques. Bioz Stars score: 86/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/qs+21/us12551543-548-0-1?v=Agenus+Inc
Average 86 stars, based on 1 article reviews
qs 21 - by Bioz Stars, 2026-07
86/100 stars
  Buy from Supplier

86
Agenus Inc qs 21 pct applications
PCT applications related to M72/AS01 E vaccine candidate filed by GSK. Patent applications may focus on the adjuvant system (green)—or its individual components 3D-MPL (yellow) <t>or</t> <t>QS-21</t> (blue)-, or on the tuberculosis vaccine (purple). Source: the authors, based on patent search and content analysis of the claims. Created in Biorender ( https://BioRender.com ).
Qs 21 Pct Applications, supplied by Agenus Inc, used in various techniques. Bioz Stars score: 86/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/qs+21/pmc12855533-157-5-13?v=Agenus+Inc
Average 86 stars, based on 1 article reviews
qs 21 pct applications - by Bioz Stars, 2026-07
86/100 stars
  Buy from Supplier

93
MedChemExpress qs
PCT applications related to M72/AS01 E vaccine candidate filed by GSK. Patent applications may focus on the adjuvant system (green)—or its individual components 3D-MPL (yellow) <t>or</t> <t>QS-21</t> (blue)-, or on the tuberculosis vaccine (purple). Source: the authors, based on patent search and content analysis of the claims. Created in Biorender ( https://BioRender.com ).
Qs, supplied by MedChemExpress, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/qs+21/us12473529-236-1-6?v=MedChemExpress
Average 93 stars, based on 1 article reviews
qs - by Bioz Stars, 2026-07
93/100 stars
  Buy from Supplier

86
Cambridge Bioscience qs 21
PCT applications related to M72/AS01 E vaccine candidate filed by GSK. Patent applications may focus on the adjuvant system (green)—or its individual components 3D-MPL (yellow) <t>or</t> <t>QS-21</t> (blue)-, or on the tuberculosis vaccine (purple). Source: the authors, based on patent search and content analysis of the claims. Created in Biorender ( https://BioRender.com ).
Qs 21, supplied by Cambridge Bioscience, used in various techniques. Bioz Stars score: 86/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/qs+21/us12447207-855-97-99?v=Cambridge+Bioscience
Average 86 stars, based on 1 article reviews
qs 21 - by Bioz Stars, 2026-07
86/100 stars
  Buy from Supplier

Image Search Results


PCT applications related to M72/AS01 E vaccine candidate filed by GSK. Patent applications may focus on the adjuvant system (green)—or its individual components 3D-MPL (yellow) or QS-21 (blue)-, or on the tuberculosis vaccine (purple). Source: the authors, based on patent search and content analysis of the claims. Created in Biorender ( https://BioRender.com ).

Journal: Frontiers in Public Health

Article Title: TB vaccine development: monitoring international patent filings to anticipate access challenges

doi: 10.3389/fpubh.2025.1726153

Figure Lengend Snippet: PCT applications related to M72/AS01 E vaccine candidate filed by GSK. Patent applications may focus on the adjuvant system (green)—or its individual components 3D-MPL (yellow) or QS-21 (blue)-, or on the tuberculosis vaccine (purple). Source: the authors, based on patent search and content analysis of the claims. Created in Biorender ( https://BioRender.com ).

Article Snippet: The applicants and/or assignees of QS-21 PCT applications are: Cambridge Corporation, Aquila Pharmaceuticals, Antigenics, Q-VANT, Desert King, Croda International and Plant Bioscience.

Techniques: Adjuvant